Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Chen, JingchunLee, Grace
Fanous, Ayman H
Zhao, Zhongming
Jia, Peilin
O'Neill, Anthony
Walsh, Dermot
Kendler, Kenneth S
Chen, Xiangning
Affiliation
Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Suite 390, 800 E. Leigh Street, Richmond, VA 23298, USA.Issue Date
2011-09MeSH
Computational BiologyDatabases, Genetic
Gene Frequency
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Linkage Disequilibrium
Meta-Analysis as Topic
Microtubule-Associated Proteins
Polymorphism, Single Nucleotide
Protein Tyrosine Phosphatases, Non-Receptor
Schizophrenia
Metadata
Show full item recordCitation
Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia. 2011, 131 (1-3):43-51 Schizophr. Res.Journal
Schizophrenia researchDOI
10.1016/j.schres.2011.06.023PubMed ID
21752600Abstract
We conducted data-mining analyses of genome wide association (GWA) studies of the CATIE and MGS-GAIN datasets, and found 13 markers in the two physically linked genes, PTPN21 and EML5, showing nominally significant association with schizophrenia. Linkage disequilibrium (LD) analysis indicated that all 7 markers from PTPN21 shared high LD (r(2)>0.8), including rs2274736 and rs2401751, the two non-synonymous markers with the most significant association signals (rs2401751, P=1.10 × 10(-3) and rs2274736, P=1.21 × 10(-3)). In a meta-analysis of all 13 replication datasets with a total of 13,940 subjects, we found that the two non-synonymous markers are significantly associated with schizophrenia (rs2274736, OR=0.92, 95% CI: 0.86-0.97, P=5.45 × 10(-3) and rs2401751, OR=0.92, 95% CI: 0.86-0.97, P=5.29 × 10(-3)). One SNP (rs7147796) in EML5 is also significantly associated with the disease (OR=1.08, 95% CI: 1.02-1.14, P=6.43 × 10(-3)). These 3 markers remain significant after Bonferroni correction. Furthermore, haplotype conditioned analyses indicated that the association signals observed between rs2274736/rs2401751 and rs7147796 are statistically independent. Given the results that 2 non-synonymous markers in PTPN21 are associated with schizophrenia, further investigation of this locus is warranted.Item Type
ArticleLanguage
enISSN
1573-2509ae974a485f413a2113503eed53cd6c53
10.1016/j.schres.2011.06.023
Scopus Count
Collections
Related articles
- GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia.
- Authors: Chen X, Lee G, Maher BS, Fanous AH, Chen J, Zhao Z, Guo A, van den Oord E, Sullivan PF, Shi J, Levinson DF, Gejman PV, Sanders A, Duan J, Owen MJ, Craddock NJ, O'Donovan MC, Blackman J, Lewis D, Kirov GK, Qin W, Schwab S, Wildenauer D, Chowdari K, Nimgaonkar V, Straub RE, Weinberger DR, O'Neill FA, Walsh D, Bronstein M, Darvasi A, Lencz T, Malhotra AK, Rujescu D, Giegling I, Werge T, Hansen T, Ingason A, Nöethen MM, Rietschel M, Cichon S, Djurovic S, Andreassen OA, Cantor RM, Ophoff R, Corvin A, Morris DW, Gill M, Pato CN, Pato MT, Macedo A, Gurling HM, McQuillin A, Pimm J, Hultman C, Lichtenstein P, Sklar P, Purcell SM, Scolnick E, St Clair D, Blackwood DH, Kendler KS, GROUP investigators, International Schizophrenia Consortium
- Issue date: 2011 Nov
- Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.
- Authors: Zeitlin AA, Heward JM, Brand OJ, Newby PR, Franklyn JA, Gough SC, Simmonds MJ
- Issue date: 2006 Sep
- Targeted sequencing of linkage region in Dominican families implicates PRIMA1 and the SPATA7-PTPN21-ZC3H14-EML5-TTC8 locus in carotid-intima media thickness and atherosclerotic events.
- Authors: Wang L, Dueker N, Beecham A, Blanton SH, Sacco RL, Rundek T
- Issue date: 2019 Aug 12
- Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2.
- Authors: O'Donovan MC, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CC, Howie B, Leung HT, Giegling I, Hartmann AM, Möller HJ, Morris DW, Shi Y, Feng G, Hoffmann P, Propping P, Vasilescu C, Maier W, Rietschel M, Zammit S, Schumacher J, Quinn EM, Schulze TG, Iwata N, Ikeda M, Darvasi A, Shifman S, He L, Duan J, Sanders AR, Levinson DF, Adolfsson R, Osby U, Terenius L, Jönsson EG, Cichon S, Nöthen MM, Gill M, Corvin AP, Rujescu D, Gejman PV, Kirov G, Craddock N, Williams NM, Owen MJ, Molecular Genetics of Schizophrenia Collaboration
- Issue date: 2009 Jan
- Functional investigation of a schizophrenia GWAS signal at the CDC42 gene.
- Authors: Gilks WP, Hill M, Gill M, Donohoe G, Corvin AP, Morris DW
- Issue date: 2012 Oct